Chandler v. Novartis Pharmaceuticals Corporation et al

Filing 12

ORDER: This case involves claims regarding the pharmaceutical drug Aredia (pamidronate), not Fosamax (alendronate), but was incorrectly accepted as a member case to In re Fosamax Prods. Liab. Litig., MDL No. 1789. The Clerk is respectfully directed to cancel this association. It appears that this case should be transferred to the Middle District of Tennessee and consolidated with In re Aredia and Zometa Prods. Liab. Litig., MDL No. 1760. The Clerk is directed to forward a copy of the complaint and this order to the Judicial Panel on Multidistrict Litigation. (Signed by Judge John F. Keenan on 9/21/2009) (jpo)

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK
EVAN CHANDLER,
Plaintiff. -against-

USDC SZFZ DOCUM EP;?' EEECT?-Q>-rlCi.iLL'ia

D

Order

NOVARTIS PHARMACEUTICALS CORPORATION, APP PHARMACEUTICALS, BEN VENUE LABORATORTIES, INC.
D/B/A BEDFORD LABORATORIES, HOSPIRA, INC, AND TEVA PARENTERAL MEDICINES, INC.

:

Defendants.

JOHN F. KEENAN, United States District Judge:

This case involves claims regarding t h e pharmaceutical drug
Aredia (pamidronate),

not

Fosamax

(alendronate),

but

was

i n c o r r e c t l y accepted as a m e m b e r case to In re Fosamax P r o d s . Liab. Litig.,
MDL No. 1789.

The C l e r k is respectfully directed

to cancel this association.

It appears that this case should be

t r a n s f e r r e d t o the Middle D i s t r i c t of Tennessee and consolidated
with In re Aredia and Zometa Prods. L i a b .

Litig., MDL No.

1760.

The C l e r k is d i r e c t e d to forward a copy of the complaint and

this o r d e r to t h e Judicial Panel on Multidistrict Litigation.
SO ORDERED.

Dated:

New York, New York September %i 2 0 0 9 J !

$%wJ

?&

JOHN F. KEENAN United S t a t e s D i s t r i c t Judge